BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0025
+0.0002 (8.70%)
Jan 20, 2026, 5:29 PM CET
BioSenic Market Cap
BioSenic has a market cap or net worth of €1.63 million as of January 20, 2026. Its market cap has decreased by -22.20% in one year.
Market Cap
1.63M
Enterprise Value
24.66M
Revenue
-2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 7.09M to 1.63M, a decrease of -76.99%. That is a compound annual growth rate of -36.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 1.50M | - |
| Dec 31, 2025 | 1.50M | -20.08% |
| Dec 31, 2024 | 1.88M | -81.19% |
| Dec 29, 2023 | 9.99M | 233.11% |
| Dec 30, 2022 | 3.00M | -57.74% |
| Oct 26, 2022 | 7.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 50.46B |
| argenx SE | 42.45B |
| Financière de Tubize | 10.48B |
| Fagron NV | 1.68B |
| Ion Beam Applications | 410.90M |
| Hyloris Pharmaceuticals | 221.20M |
| Onward Medical | 202.43M |
| Nyxoah | 186.95M |